Skip to main content
. 2018 Oct 5;8(18):4985–4994. doi: 10.7150/thno.27728

Figure 3.

Figure 3

68Ga-sCD146 biodistribution studies. (A) Representative biodistribution obtained by PET imaging. (B) Biodistribution studies obtained by gamma counting 120 min post-injection (n = 3). (C) Image-derived time activity curves for heart, liver, lung, brain, bones, intestines and muscles (n = 3). (D) 68Ga-sCD146 biodistribution in bladder and kidneys. (n = 3). Results showed that 68Ga-sCD146 was mostly eliminated by the urinary and hepatobiliary route.